Xunming Zhang
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- Lymphatic System and Diseases
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Protein Hydrolysis and Bioactive Peptides 3
- Glycosylation and Glycoproteins Research 2
- Oncology 4
- CAR-T cell therapy research 3
- Co-authors
- Lei Zhao (6 shared papers)Bohua Li (6 shared papers)Weizhu Qian (5 shared papers)Lan Wu (3 shared papers)Chong Wang (3 shared papers)Linlin Hao (6 shared papers)Yajun Guo (4 shared papers)Huaizu Guo (2 shared papers)
In The Last Decade
Xunming Zhang
16 papers receiving 286 citations
Peers
Comparison fields: 5 of 73
- Radiology, Nuclear Medicine and Imaging 79
- Oncology 66
- Genetics 26
- Immunology 42
- Biomaterials 21
Countries citing papers authored by Xunming Zhang
This map shows the geographic impact of Xunming Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xunming Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xunming Zhang more than expected).
Fields of papers citing papers by Xunming Zhang
This network shows the impact of papers produced by Xunming Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xunming Zhang. The network helps show where Xunming Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xunming Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 67 | |
| 2 | 2010 | 49 | |
| 3 | 2023 | 48 | |
| 4 | 2009 | 20 | |
| 5 | 2010 | 20 | |
| 6 | 2023 | 19 | |
| 7 | 2019 | 17 | |
| 8 | 2023 | 14 | |
| 9 | 2020 | 11 | |
| 10 | 2010 | 10 | |
| 11 | 2024 | 8 | |
| 12 | 2010 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Xunming Zhang
Xunming Zhang is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Animal Science and Zoology, having authored 18 papers that have together received 295 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Protein Hydrolysis and Bioactive Peptides (3 papers), CAR-T cell therapy research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Glycosylation and Glycoproteins Research (2 papers), Insect Utilization and Effects (2 papers), Meat and Animal Product Quality (2 papers) and Membrane Separation Technologies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (79 citations), Oncology (66 citations), Genetics (26 citations), Immunology (42 citations) and Biomaterials (21 citations). Xunming Zhang has collaborated with scholars based in China, Hong Kong and India. Frequent co-authors include Lei Zhao, Bohua Li, Weizhu Qian, Lan Wu, Chong Wang, Linlin Hao, Yajun Guo, Huaizu Guo, Zhaoguo Wang and Jingping Shi. Their work appears in journals such as Cancer Letters, Cancer Research, Frontiers in Physiology, Antioxidants and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.